OCTAVE SPECIALTY GROUP INC (OSG) Form 8-K — Aug 6, 2026
Octave Specialty Group (NYSE: OSG) reported second quarter 2026 total revenue of $83.0 million, up 51% year over year, driven by its Insurance Distribution segment, where revenue grew 77% to $58.4 million with 44% organic growth. The company narrowed its Q2 net loss to shareholders to $14.4 million from $20.5 million a year ago, while Adjusted EBITDA to shareholders swung to a positive $3.7 million from a negative $4.6 million, helped by the 2025 ArmadaCare acquisition and an increased 70% stake in Octave Ventures.
Key figures
- Revenue
- 82995000
- Guidance
- Updated 2026 guidance to be discussed on the August 7, 2026 earnings call; no specific guidance figures included in the release.
- Total Debt
- 155459000
- Revenue Yoy
- 51%
- Total Assets
- 2280857000
- Cash Position
- 79096000
- Shares Outstanding
- 48876882
- Everspan loss ratio
- 61.4% vs 67.8% in 2Q25
- Everspan net income
- $1.1 million vs $0.4 million in 2Q25
- Book value per share
- $15.52 at June 30, 2026
- Everspan combined ratio
- 100.6% vs 106.7% in 2Q25 (improved 610 bps)
- Six month total revenue
- $187.2 million, up 59% YoY
- Cash including restricted
- $79.1 million cash and equivalents, of which $52.3 million restricted
- Everspan net premiums written
- $23.1 million, up 52% YoY
- Insurance distribution revenue
- $58.4 million, up 77% YoY
- Adjusted ebitda to shareholders
- $3.7 million vs $(4.6) million in 2Q25
- Everspan gross premiums written
- $94.7 million, down 2% YoY
- Weighted average diluted shares
- 45391000
- Adjusted net loss to shareholders
- $(1.8) million vs $(10.6) million in 2Q25
- Organic revenue growth insurance distribution
- 44.1%
Price after filing
Close on the filing date to close N calendar days later (from $5.63). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.